open access
Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer
open access
Abstract
Material and methods: Total RNA was isolated from 38 paired normal and PTC samples. 0.5 μg of RNA was used in the reverse transcription reaction. cDNA was further used in Q-PCR reaction. As endogenous control we used GUS gene, as its expression was stable in all analysed samples.
Results: The analyzed genes were found by microarray studies as characteristic in differentiated papillary carcinoma and normal tissue. The levels of gene expression, estimated by quantitative analysis of particular transcripts were increased in papillary thyroid carcinoma with the following average values: 0.76 for MMP11; 1.08 for CLDN1; 3.98 for LRP4; 4.57 for FLRT3; 26.6 for MRC2; 2.76 for NRCAM; and 1.35 for EVA1 (arbitrary units), whereas in normal thyroid tissues treated as control the respective values were: 0.09; 0.145; 0.7; 0.74; 7.9; 0.85 and 0.396 units. To confirm the overexpression of mentioned genes the conservative Kolmogorov- Smirnov test was used. Differences in expression between normal thyroid tissue and PTC were statistically significant.
Conclusions: Among the analyzed genes two show the largest difference in expression between papillary thyroid cancer and normal tissue: MMP11 (metalloproteinase 11) and CLDN1 (claudin 1). The MMP11 gene can be characteristic for various malignant thyroid carcinomas, because its increased levels are present also in medullary thyroid carcinomas. It appears that claudin 1 may be used as a marker of PTC, however a verification on independent collection of tumors of this result is required.
Abstract
Material and methods: Total RNA was isolated from 38 paired normal and PTC samples. 0.5 μg of RNA was used in the reverse transcription reaction. cDNA was further used in Q-PCR reaction. As endogenous control we used GUS gene, as its expression was stable in all analysed samples.
Results: The analyzed genes were found by microarray studies as characteristic in differentiated papillary carcinoma and normal tissue. The levels of gene expression, estimated by quantitative analysis of particular transcripts were increased in papillary thyroid carcinoma with the following average values: 0.76 for MMP11; 1.08 for CLDN1; 3.98 for LRP4; 4.57 for FLRT3; 26.6 for MRC2; 2.76 for NRCAM; and 1.35 for EVA1 (arbitrary units), whereas in normal thyroid tissues treated as control the respective values were: 0.09; 0.145; 0.7; 0.74; 7.9; 0.85 and 0.396 units. To confirm the overexpression of mentioned genes the conservative Kolmogorov- Smirnov test was used. Differences in expression between normal thyroid tissue and PTC were statistically significant.
Conclusions: Among the analyzed genes two show the largest difference in expression between papillary thyroid cancer and normal tissue: MMP11 (metalloproteinase 11) and CLDN1 (claudin 1). The MMP11 gene can be characteristic for various malignant thyroid carcinomas, because its increased levels are present also in medullary thyroid carcinomas. It appears that claudin 1 may be used as a marker of PTC, however a verification on independent collection of tumors of this result is required.
Keywords
papillary thyroid cancer; gene expression profile; cell adhesion; Q-PCR


Title
Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer
Journal
Issue
Article type
Original paper
Pages
18-25
Published online
2006-09-25
Page views
536
Article views/downloads
1204
Keywords
papillary thyroid cancer
gene expression profile
cell adhesion
Q-PCR
Authors
Joanna Hucz
Małgorzata Kowalska
Michał Jarząb
Małgorzata Wiench